Rare diseases
Investigational molecules
Locations
Back to Portugal638 clinical trials in Lisbon, Portugal across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Study on Remibrutinib for Adults with Chronic Inducible Urticaria Uncontrolled by H1-Antihistamines
PortugalStudy on Batoclimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
PortugalStudy on Anifrolumab for Adults with Chronic or Subacute Cutaneous Lupus Erythematosus Unresponsive to Antimalarial Therapy
PortugalStudy of petosemtamab with pembrolizumab compared to pembrolizumab alone in patients with head and neck cancer who have not received previous treatment for advanced disease
PortugalStudy of petosemtamab compared to standard therapy in previously treated patients with metastatic or recurrent head and neck cancer
PortugalStudy of Cabozantinib and Atezolizumab Compared to Hormonal Therapy in Adults with Metastatic Castration-Resistant Prostate Cancer
PortugalStudy on the Safety of Acoramidis in Patients with Transthyretin Amyloid Cardiomyopathy Who Completed a Previous Trial
PortugalStudy of Domvanalimab, Zimberelimab, and Chemotherapy for Patients with Advanced Esophageal or Gastric Cancer
PortugalStudy on the Effectiveness and Safety of BHV-7000 for Adults with Refractory Focal Onset Epilepsy
PortugalStudy on the Effectiveness and Safety of Sonelokimab for Adults with Moderate to Severe Hidradenitis Suppurativa
PortugalStudy on the Long-Term Safety of Nintedanib for Children and Adolescents with Interstitial Lung Disease
PortugalStudy Comparing Ribociclib and Palbociclib for Patients with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
PortugalThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on head and neck cancer treatments and advanced lung cancer therapies, combining novel approaches with standard treatments.
Studies evaluate targeted therapies and immunotherapy combinations to improve patient outcomes.
Comprehensive research into various autoimmune disorders, with particular focus on psoriasis and systemic sclerosis treatments.
Testing innovative biological therapies and novel treatment approaches.
Studies examining treatments for Dravet Syndrome and Alzheimer's-related psychosis, focusing on improving patient quality of life.
Investigating new therapeutic options for challenging neurological conditions.
Research targeting Crohn's Disease and various inflammatory conditions, evaluating new treatment combinations.
Testing advanced therapies for chronic inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
